Table 2.
No. | Sex | Age | Comorbidities | Presentation 1 | Phase 2 | Main Symptoms 2 | Time Since Onset 2 | Anti-TBEV IgM in Serum 2 | TBEV RNA in Plasma (ct Value) |
TBEV RNA in Whole Blood (ct Value) |
TBEV RNA in CSF 2 |
Follow Up TBEV RNA |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 68 | hypertension, hyperuricaemia, Lyme borreliosis | MEM | neurologic | headache, vertigo, neck stiffness, flaccid paresis |
19 days; neurologic phase—8 days |
negative | 30.6 | 32.0 | negative | ND |
2 | F | 51 | none | meningitis | peripheral | fever, arthralgia, headache |
5 days | negative | 32.6 | negative | ND | negative plasma and CSF on day 17 (6th day of the neurologic phase) |
3 | F | 59 | possible Lyme borreliosis | meningitis | peripheral | fever, headache, maculopapular rash |
4 days | negative | 32.5 | negative | negative | ND |
4 | F | 31 | none | abortive infection | peripheral | headache, myalgia, nausea, neck stiffness |
3 days | negative | 35.2 | negative | negative | ND |
1 Final diagnosis on discharge. 2 At the time of the TBEV RNA-positive plasma sample collection. M—male; F—female; MEM—meningoencephalomyelitis; ND—not done.